AC

ADAR1 Capital

Hedge Fund

ADAR1 Capital is a Hedge Fund firm.

ADAR1 Capital Management is a biotechnology and healthcare-focused hedge fund managing over $1.3B AUM, with investments in clinical-stage biotechs and notable exits like Evommune.

Late Stage
Growth
Biotech
Healthcare
AUM
$1.4B
Portfolio Companies
5
Recorded investments
5
Latest recorded investment
Apr 2026
Geographic Focus
United States
Use investor data through the API.
Example request
curl "https://indexed.vc/api/v1/investors/adar1-capital?depth=slim" -H "X-API-Key: YOUR_API_KEY"

Indexed holds 5 portfolio companies and 5 funding rounds for this investor. to use credits for reveals, or explore the API.

Overview

Indexed has recorded 5 investments for ADAR1 Capital. Its portfolio includes Acumen Pharmaceuticals, Kalaris Therapeutics and Fractyl Health. Focus areas include Biotech and Healthcare.

Portfolio5

Co-investors24

Sign up to view co-investors

Up to 24 co-investors shown

Venture Capital ×15 · Hedge Fund ×3 · Family Office ×2

Recorded investments5

Data from Indexed.vcUpdated

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

ADAR1 Capital on Indexed.vc
<a href="https://indexed.vc/investors/adar1-capital"><img src="https://indexed.vc/api/badge/investor/adar1-capital" alt="ADAR1 Capital on Indexed.vc" width="260" height="76" /></a>